Showing results (451-460 of 576) with videos related to

Sort By:
Pageof 58
BMJ Open Diabetes Research & Care|October 15, 2020
Lower resource utilization for patients with healed diabetic foot ulcers during participation in a prevention program with foot temperature monitoringAdam L Isaac, Timothy D Swartz, Mark L Miller, et al.
American Journal of Hematology|July 31, 2016
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapyNicholas J Short, Christopher B Benton, Hsiang-Chun Chen, et al.
American Journal of Hematology|September 19, 2022
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypesDaniel Rivera, Kunhwa Kim, Rashmi Kanagal-Shamanna, et al.
JCO Precision Oncology|May 17, 2023
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class RearrangementsJayastu Senapati, Elias Jabbour, Marina Konopleva, et al.
Blood Advances|December 19, 2023
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclaxAlex Bataller, Alexandre Bazinet, Courtney D DiNardo, et al.
American Journal of Hematology|January 12, 2017
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agentsElias Jabbour, Paolo Strati, Monica Cabrero, et al.
Cancers|November 27, 2024
Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center ExperienceDavid McCall, Shaikha Alqahtani, Moriah Budak, et al.
Nature Communications|October 13, 2019
Contribution of retrotransposition to developmental disordersEugene J Gardner, Elena Prigmore, Giuseppe Gallone, et al.
JNCI Cancer Spectrum|June 27, 2025
Risk of early death after acute leukemia diagnosis among adolescents and young adultsAmy M Berkman, Clark R Andersen, Vidya Puthenpura, et al.
Blood Advances|December 4, 2024
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapyWei-Ying Jen, Koji Sasaki, Farhad Ravandi, et al.
Pageof 58